Helios is a formulation that combines two active compounds: Clenbuterol, a β₂-adrenergic receptor agonist, and Yohimbine, an α₂-adrenergic receptor antagonist. This blend is typically studied for its synergistic effects on adrenergic signaling pathways and lipid metabolism.